Elicio Therapeutics, Inc.·4

Apr 16, 5:12 PM ET

Shah Preetam 4

4 · Elicio Therapeutics, Inc. · Filed Apr 16, 2025

Insider Transaction Report

Form 4
Period: 2025-04-15
Shah Preetam
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-04-15+191,624191,624 total
    Exercise: $4.98Exp: 2035-04-15Common Stock (191,624 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable as to 25% of the options on March 24, 2025, the first anniversary of the Reporting Person's start date, with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Documents

1 file
  • 4
    wk-form4_1744837936.xmlPrimary

    FORM 4